|
Volumn 107, Issue 1-3, 2002, Pages 71-77
|
Decreased monoamine release in the median preoptic area following ventricular treatment with the angiotensin II antagonist saralasin in normotensive and spontaneously hypertensive rats
|
Author keywords
Median preoptic nucleus; Microdialysis; Saralasin; Spontaneously hypertensive rat; Subfornical organ; Wistar Kyoto rat
|
Indexed keywords
3,4 DIHYDROXYPHENYLACETIC ACID;
ANGIOTENSIN II ANTAGONIST;
DOPAMINE;
HOMOVANILLIC ACID;
MONOAMINE;
NORADRENALIN;
SARALASIN;
ANGIOTENSIN II;
BIOGENIC AMINE;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
BRAIN THIRD VENTRICLE;
CONTROLLED STUDY;
DOPAMINE RELEASE;
DRUG EFFECT;
EXTRACELLULAR SPACE;
MALE;
MICRODIALYSIS;
MONOAMINE RELEASE;
NONHUMAN;
NORADRENALIN RELEASE;
PREOPTIC NUCLEUS;
PRIORITY JOURNAL;
RAT;
RAT STRAIN;
SPONTANEOUSLY HYPERTENSIVE RAT;
STRAIN DIFFERENCE;
ANIMAL;
BIOSYNTHESIS;
CYTOLOGY;
DRUG ANTAGONISM;
HYPERTENSION;
INTRACEREBROVENTRICULAR DRUG ADMINISTRATION;
NERVE CELL;
NERVE TRACT;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
PREOPTIC AREA;
SUBFORNICAL ORGAN;
WISTAR KYOTO RAT;
ANGIOTENSIN II;
ANIMAL;
BIOGENIC MONOAMINES;
HYPERTENSION;
INJECTIONS, INTRAVENTRICULAR;
MALE;
MICRODIALYSIS;
NEURAL PATHWAYS;
NEURONS;
PREOPTIC AREA;
RATS;
RATS, INBRED SHR;
RATS, INBRED WKY;
SARALASIN;
SUBFORNICAL ORGAN;
ANIMALS;
|
EID: 0037098969
PISSN: 01670115
EISSN: None
Source Type: Journal
DOI: 10.1016/S0167-0115(02)00071-X Document Type: Article |
Times cited : (7)
|
References (36)
|